Clinical Trials
9
Active:0
Completed:6
Trial Phases
3 Phases
Phase 1:5
Phase 2:2
Phase 3:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (9 trials with phase data)• Click on a phase to view related trials
Phase 1
5 (55.6%)Phase 2
2 (22.2%)Phase 3
2 (22.2%)A Sudy to Evaluate the Efficacy and Safety of TNM001 in High-risk Infants
Phase 3
Not yet recruiting
- Conditions
- Respiratory Syncytial Virus Infections
- Interventions
- Biological: placebo
- First Posted Date
- 2024-11-29
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- Zhuhai Trinomab Pharmaceutical Co., Ltd.
- Target Recruit Count
- 201
- Registration Number
- NCT06710925
- Locations
- 🇨🇳
West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China
🇨🇳Children's Hospital of Chongqing Medical University, Chongqing, Sichuan, China
A Randomized, Open-Label, Parallel-Design Pharmacokinetic and Pharmacodynamic Interaction Study of TNM002 and Adsorbed Tetanus Vaccine
Phase 1
Completed
- Conditions
- Tetanus
- Interventions
- First Posted Date
- 2024-09-23
- Last Posted Date
- 2024-09-23
- Lead Sponsor
- Zhuhai Trinomab Pharmaceutical Co., Ltd.
- Target Recruit Count
- 60
- Registration Number
- NCT06607380
- Locations
- 🇨🇳
PKUCare Luzhong Hospital, Zibo, Shandong, China
A Trial to Evaluate the Efficacy and Safety of TNM001 for the Prevention of Lower Respiratory Tract Infection Caused by Respiratory Syncytial Virus in Infants
Phase 2
Not yet recruiting
- Conditions
- Respiratory Syncytial Virus Infections
- First Posted Date
- 2023-10-16
- Last Posted Date
- 2023-10-16
- Lead Sponsor
- Zhuhai Trinomab Pharmaceutical Co., Ltd.
- Target Recruit Count
- 2250
- Registration Number
- NCT06083623
- Locations
- 🇨🇳
Peking University Third Hospital, Beijing, Beijing, China
🇨🇳Children's Hospital Capital Institute Pediatrics, Beijing, Beijing, China
🇨🇳Jiangjin Central Hospital, Chongqing, Chongqing, China
A Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamic Profile of TNM005 in Healthy Adult Subjectsy
- First Posted Date
- 2023-10-05
- Last Posted Date
- 2024-07-11
- Lead Sponsor
- Zhuhai Trinomab Pharmaceutical Co., Ltd.
- Target Recruit Count
- 48
- Registration Number
- NCT06068608
- Locations
- 🇺🇸
ICON, plc, Salt Lake City, Utah, United States
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TNM002 in Chinese Healthy Adults
- First Posted Date
- 2023-05-06
- Last Posted Date
- 2023-05-06
- Lead Sponsor
- Zhuhai Trinomab Pharmaceutical Co., Ltd.
- Target Recruit Count
- 28
- Registration Number
- NCT05842798
- Locations
- 🇨🇳
The Fifth Affiliated Hospital Sun Yat-sen University, Zhuhai, Guangdong, China
- Prev
- 1
- 2
- Next
News
No news found